Pathria G - Search Results

1

Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.

Pathria G, Wagner C, Wagner SN. Pathria G, et al. J Invest Dermatol. 2012 Dec;132(12):2780-90. doi: 10.1038/jid.2012.233. Epub 2012 Jul 26. J Invest Dermatol. 2012. PMID: 22832492 Free article.

2

Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.

Pathria G, Garg B, Borgdorff V, Garg K, Wagner C, Superti-Furga G, Wagner SN. Pathria G, et al. Cell Death Dis. 2016 Mar 10;7(3):e2135. doi: 10.1038/cddis.2015.369. Cell Death Dis. 2016. PMID: 26962685 Free PMC article.

3

Dual c-Jun N-terminal kinase-cyclin D1 and extracellular signal-related kinase-c-Jun disjunction in human melanoma.

Pathria G, Garg B, Garg K, Wagner C, Wagner SN. Pathria G, et al. Br J Dermatol. 2016 Dec;175(6):1221-1231. doi: 10.1111/bjd.14713. Epub 2016 Sep 20. Br J Dermatol. 2016. PMID: 27145925

4

Polo-like kinase 1 is a potential therapeutic target in human melanoma.

Jalili A, Moser A, Pashenkov M, Wagner C, Pathria G, Borgdorff V, Gschaider M, Stingl G, Ramaswamy S, Wagner SN. Jalili A, et al. Among authors: pathria g. J Invest Dermatol. 2011 Sep;131(9):1886-95. doi: 10.1038/jid.2011.136. Epub 2011 Jun 9. J Invest Dermatol. 2011. PMID: 21654832 Free article.

5

Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.

Jalili A, Wagner C, Pashenkov M, Pathria G, Mertz KD, Widlund HR, Lupien M, Brunet JP, Golub TR, Stingl G, Fisher DE, Ramaswamy S, Wagner SN. Jalili A, et al. Among authors: pathria g. J Natl Cancer Inst. 2012 Nov 7;104(21):1673-9. doi: 10.1093/jnci/djs373. Epub 2012 Sep 20. J Natl Cancer Inst. 2012. PMID: 22997239 Free PMC article.

6

NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo.

Jalili A, Mertz KD, Romanov J, Wagner C, Kalthoff F, Stuetz A, Pathria G, Gschaider M, Stingl G, Wagner SN. Jalili A, et al. Among authors: pathria g. PLoS One. 2013 Jul 30;8(7):e69064. doi: 10.1371/journal.pone.0069064. Print 2013. PLoS One. 2013. PMID: 23935925 Free PMC article.

7

RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.

Pathria G, Garg B, Wagner C, Garg K, Gschaider M, Jalili A, Wagner SN. Pathria G, et al. J Invest Dermatol. 2016 Jan;136(1):264-74. doi: 10.1038/JID.2015.401. J Invest Dermatol. 2016. PMID: 26763446 Free article.

8

Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stress.

Garg B, Pathria G, Wagner C, Maurer M, Wagner SN. Garg B, et al. Among authors: pathria g. Mutagenesis. 2016 Sep;31(5):573-82. doi: 10.1093/mutage/gew023. Epub 2016 May 14. Mutagenesis. 2016. PMID: 27180333

9

MTSS1 is a metastasis driver in a subset of human melanomas.

Mertz KD, Pathria G, Wagner C, Saarikangas J, Sboner A, Romanov J, Gschaider M, Lenz F, Neumann F, Schreiner W, Nemethova M, Glassmann A, Lappalainen P, Stingl G, Small JV, Fink D, Chin L, Wagner SN. Mertz KD, et al. Among authors: pathria g. Nat Commun. 2014 Mar 17;5:3465. doi: 10.1038/ncomms4465. Nat Commun. 2014. PMID: 24632752 Free article.

10

Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.

Feng Y, Pathria G, Heynen-Genel S, Jackson M, James B, Yin J, Scott DA, Ronai ZA. Feng Y, et al. Among authors: pathria g. Mol Cancer Ther. 2021 May;20(5):816-832. doi: 10.1158/1535-7163.MCT-20-0354. Epub 2021 Feb 25. Mol Cancer Ther. 2021. PMID: 33632871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page